Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of MenABCWY Combination Vaccines in Adolescents
NCT01272180Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2011
- Primary completion
- Oct 2011
- Modality
- Split/Subunit Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of Meningococcal ABCWY in meningococcal disease, sponsored by Novartis. Started Aug 2011; status: completed.
02
Drugs
Meningococcal ABCWY
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01272180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01272180.